About | Iambic Therapeutics

About

Drug discovery driven by people, amplified by AI

Nobel Prize. Caltech, President's Science and Tech Advisory Board, Alphabet Board of Directors.

Alex A. Adjei, MD

Chair of Taussig Cancer Institute, Cleveland Clinic.

Former head of research at Principia, Co-founder of Alumis.

MIT Professor, autonomous discovery and machine learning.

Scripps Research Board of Directors, previously ARCH and Celgene.

Maria Koehler, MD

CMO of Repare Therapeutics, previously Pfizer.

Novartis Director of Chemical Biology Therapeutics, Author of Science “In the Pipeline” blog.

Former CSO Array BioPharma and Pfizer Boulder.

USCF professor, Cofounder of Principia and Global Blood Therapeutics.

Kwok-Kin Wong, MD

Director of Hematology and Medical Oncology, NYU Langone Health.

Jackie Walling; MBChB, Ph.D

CEO of Consulting JW LLC

Former CSO and CEO of Plexxikon

CEO

CTO

CMO

SVP, Discovery Biology

SVP, Business Development

VP, Chemistry

Prasad Gullapalli

VP, Pharm Dev

VP, Biology

VP, Finance

VP, Analytical

Exec. Director, Automation

Exec. Director, Machine Learning

Board

Tom Miller

Co-founder & CEO

Fred Manby

Co-founder & CTO

William Rastetter

Independent Board Member

Jishnu Bhattacharjee

Nexus Venture

Evan Rachlin

Ascenta Capital

Jacob Vogelstein

Catalio Capital

Kurt von Emster

Abingworth

Investors

Headquartered
in San Diego

Our headquarters and state-of-the-art laboratory facilities are located in La Jolla.